Showing results (1641-1650 of 2,464) with videos related to

Sort By:
Pageof 247
DNA and Cell Biology|July 1, 1990
The uses of computer-aided signal peptide selection and polymerase chain reaction in gene construction and expression of secreted proteinsB L Daugherty, S M Zavodny, A B Lenny, et al.
Expert Review of Hematology|February 23, 2019
Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapyUtkarsh H Acharya, Tejaswini Dhawale, Seongseok Yun, et al.
Biochemical Society Transactions|October 26, 2005
Aberrant termination triggers nonsense-mediated mRNA decayN Amrani, S Dong, F He, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2019
Novel compounds that reverse the disease phenotype in Type 2 Gaucher disease patient-derived cellsWayne Childers, Rong Fan, Rogelio Martinez, et al.
Orthopedics|May 14, 2015
Platelet-rich plasma does not decrease blood loss in total knee arthroplastyEdwin M Tingstad, Sarah N Bratt, Kasee J Hildenbrand, et al.
Neuropharmacology|November 19, 1997
Pharmacological characterization of novel A3 adenosine receptor-selective antagonistsK A Jacobson, K S Park, J L Jiang, et al.
Journal of Medicinal Chemistry|August 10, 2001
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: irreversible antagonists at the human A3 adenosine receptor and molecular modeling studiesP G Baraldi, B Cacciari, S Moro, et al.
Journal of Medicinal Chemistry|July 22, 2005
"Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonistsMelissa Perreira, Jian-Kang Jiang, Athena M Klutz, et al.
Biochemical and Biophysical Research Communications|April 27, 2018
Citrus bioflavonoids dipeptidyl peptidase-4 inhibition compared with gliptin antidiabetic medicationsAnkit Gupta, Glenn A Jacobson, John R Burgess, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 21, 2006
Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptorZhi-Dong Ge, Jason N Peart, Laura M Kreckler, et al.
Pageof 247